Supplementation with Lactobacillus reuteri ATCC PTA 4659 in patients affected by acute uncomplicated diverticulitis: a randomized double-blind placebo controlled trial

[1]  A. Gasbarrini,et al.  The Use of Probiotics in Different Phases of Diverticular Disease. , 2018, Reviews on recent clinical trials.

[2]  M. Boermeester,et al.  Long‐Term Effects of Omitting Antibiotics in Uncomplicated Acute Diverticulitis , 2018, The American Journal of Gastroenterology.

[3]  M. Cabana,et al.  Lactobacillus reuteri to Treat Infant Colic: A Meta-analysis , 2018, Pediatrics.

[4]  C. Kvasnovsky,et al.  A randomized double-blind placebo-controlled trial of a multi-strain probiotic in treatment of symptomatic uncomplicated diverticular disease , 2017, Inflammopharmacology.

[5]  A. Tursi,et al.  Management of diverticulosis: what's new? , 2017, Minerva medica.

[6]  G. Maconi.  Diagnosis of symptomatic uncomplicated diverticular disease and the role of Rifaximin in management , 2017, Acta bio-medica : Atenei Parmensis.

[7]  N. Kawasaki,et al.  Lactobacillus reuteri Surface Mucus Adhesins Upregulate Inflammatory Responses Through Interactions With Innate C-Type Lectin Receptors , 2017, Front. Microbiol..

[8]  S. Kuk,et al.  Microbiota: In Health and in Sickness, From Birth to Death. , 2016, Turkiye parazitolojii dergisi.

[9]  I. Hirano,et al.  American Gastroenterological Association Institute Guideline on the Management of Acute Diverticulitis. , 2015, Gastroenterology.

[10]  B. Dousset,et al.  [Treatment of the acute diverticulitis: A systematic review]. , 2015, Presse medicale.

[11]  T. Wedel,et al.  [Diverticular disease - new insights into pathogenesis]. , 2015, Deutsche medizinische Wochenschrift.

[12]  R. Talukdar,et al.  Role of the normal gut microbiota. , 2015, World journal of gastroenterology.

[13]  D. Collins,et al.  Modern Concepts in Diverticular Disease , 2015, Journal of clinical gastroenterology.

[14]  Laura Magrini,et al.  Overcrowding in emergency department: an international issue , 2015, Internal and Emergency Medicine.

[15]  Michael C Bogseth.  Surgery for Diverticulitis in the 21st Century a Systematic Review , 2014 .

[16]  S. Hendren,et al.  Surgery for diverticulitis in the 21st century: a systematic review. , 2014, JAMA surgery.

[17]  T. Wedel,et al.  [Anatomy and pathogenesis of diverticular disease]. , 2014, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

[18]  T. Wedel,et al.  Anatomie und Pathogenese der Divertikelkrankheit , 2014, Der Chirurg.

[19]  M. Drews,et al.  Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis—a prospective randomized study , 2013, International Journal of Colorectal Disease.

[20]  T. Wilkins,et al.  Diagnosis and management of acute diverticulitis. , 2013, American family physician.

[21]  B. Spiegel,et al.  Diverticular Disease as a Chronic Illness: Evolving Epidemiologic and Clinical Insights , 2012, The American Journal of Gastroenterology.

[22]  J. M. Rhoads,et al.  Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-κB signaling in the intestine. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[23]  Á. Lanas,et al.  Management of colonic diverticular disease with poorly absorbed antibiotics and other therapies , 2011, Therapeutic advances in gastroenterology.

[24]  Luci K. Leykum,et al.  Implementation of a hospitalist-run observation unit and impact on length of stay (LOS): a brief report. , 2010, Journal of hospital medicine.

[25]  J. M. Rhoads,et al.  Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[26]  C. Floch.  Diagnosis and Management of Acute Diverticulitis , 2006, Journal of clinical gastroenterology.

[27]  A. Tursi,et al.  Mesalazine and/or Lactobacillus casei in Preventing Recurrence of Symptomatic Uncomplicated Diverticular Disease of the Colon: A Prospective, Randomized, Open-label Study , 2006, Journal of clinical gastroenterology.

[28]  M. Zavoral,et al.  The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon , 2003, European journal of gastroenterology & hepatology.

[29]  Hinchey Ej,et al.  Treatment of perforated diverticular disease of the colon. , 1978 .